Ikena Oncology, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 11/13/2024 | 5.02 M | $8.68 M | 0.00% | 10.40% |
| BVF INC/IL | 11/14/2024 | 4.77 M | $8.25 M | 0.00% | 9.88% |
| BLUE OWL CAPITAL HOLDINGS LP | 11/14/2024 | 4.09 M | $7.08 M | 0.00% | 8.48% |
| ORBIMED ADVISORS LLC | 11/14/2024 | 3.54 M | $6.12 M | 0.00% | 7.33% |
| OMEGA FUND MANAGEMENT, LLC | 11/14/2024 | 2.25 M | $3.89 M | 0.00% | 4.66% |
| VANGUARD GROUP INC | 11/13/2024 | 1.38 M | $2.40 M | 1.48% | 2.87% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 987,900 | $1.71 M | 0.00% | 2.05% |
| BML CAPITAL MANAGEMENT, LLC | 11/05/2024 | 723,288 | $1.25 M | 23.61% | 1.50% |
| NEA MANAGEMENT COMPANY, LLC | 11/14/2024 | 600,063 | $1.04 M | 5.27% | 1.24% |
| ACUITAS INVESTMENTS, LLC | 11/07/2024 | 449,656 | $777,905 | 12.45% | 0.93% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 400,600 | $693,038 | -15.91% | 0.83% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 388,748 | $672,534 | -8.40% | 0.81% |
| SOFINNOVA INVESTMENTS, INC. | 11/13/2024 | 382,616 | $661.93 M | 0.00% | 0.79% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 352,176 | $609,264 | 100.00% | 0.73% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 325,713 | $562,000 | 0.00% | 0.67% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 271,026 | $468,977 | 5.58% | 0.56% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 249,417 | $431,491 | -29.68% | 0.52% |
| FNY INVESTMENT ADVISERS, LLC | 10/18/2024 | 231,383 | $400,000 | 100.00% | 0.48% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 202,100 | $349,633 | 16.69% | 0.42% |
| BARCLAYS PLC | 11/19/2024 | 195,311 | $338,000 | -0.37% | 0.40% |
| CITADEL ADVISORS LLC | 11/14/2024 | 165,015 | $285,476 | -32.56% | 0.34% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 158,400 | $274,032 | 92.47% | 0.33% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 156,713 | $271,113 | -33.84% | 0.32% |
| BBR PARTNERS, LLC | 11/13/2024 | 130,000 | $224,900 | 550.00% | 0.27% |
| VAZIRANI ASSET MANAGEMENT LLC | 11/14/2024 | 115,668 | $200,106 | 100.00% | 0.24% |
| DEUTERIUM CAPITAL MANAGEMENT, LLC | 11/13/2024 | 80,579 | $139,402 | 0.00% | 0.17% |
| STATE STREET CORP | 11/14/2024 | 80,353 | $139,011 | 0.00% | 0.17% |
| MARQUETTE ASSET MANAGEMENT, LLC | 10/08/2024 | 72,890 | $126,100 | 0.00% | 0.15% |
| JBF CAPITAL, INC. | 11/14/2024 | 72,647 | $125,679 | 0.00% | 0.15% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 58,623 | $101,417 | -78.59% | 0.12% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 57,090 | $98,766 | -31.40% | 0.12% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 11/14/2024 | 50,638 | $87,604 | 100.00% | 0.10% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 44,635 | $77,219 | -4.39% | 0.09% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 38,621 | $66,814 | 0.00% | 0.08% |
| FMR LLC | 11/13/2024 | 38,374 | $66,387 | 94.13% | 0.08% |
| JANE STREET GROUP, LLC | 11/15/2024 | 37,270 | $64,477 | -33.26% | 0.08% |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 11/13/2024 | 24,830 | $42,956 | 0.00% | 0.05% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 11/14/2024 | 22,146 | $38,313 | -51.35% | 0.05% |
| BERKSHIRE ASSET MANAGEMENT LLC/PA | 11/14/2024 | 20,000 | $33,000 | 0.00% | 0.04% |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 11/12/2024 | 17,795 | $30,785 | -2.81% | 0.04% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 17,352 | $30,019 | -50.34% | 0.04% |
| MORGAN STANLEY | 11/14/2024 | 15,403 | $26,647 | -62.32% | 0.03% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 12,066 | $20,874 | 0.00% | 0.03% |
| LPL FINANCIAL LLC | 11/08/2024 | 12,000 | $20,760 | 100.00% | 0.02% |
| POINT72 (DIFC) LTD | 11/14/2024 | 6,716 | $11,619 | 52.91% | 0.01% |
| 11/14/2024 | 4,500 | $7,785 | 0.00% | 0.01% | |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 2,728 | $4,719 | 17.79% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 1,875 | $3,244 | -90.69% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 1,503 | $2,600 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 11/08/2024 | 849 | $1,469 | 0.00% | 0.00% |
Ikena Oncology, Inc.institutional Ownership - FAQ's
During the previous two years, 79 institutional investors and hedge funds held shares of Ikena Oncology, Inc.. The most heavily invested institutionals were:
Atlas Venture Life Science Advisors, LLC: 5.02 M
BVF INC/IL: 4.77 M
Blue Owl Capital Holdings LP: 4.09 M
ORBIMED ADVISORS LLC: 3.54 M
Omega Fund Management, LLC: 2.25 M
VANGUARD GROUP INC: 1.38 M
58.87% of Ikena Oncology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 30.89 M shares in the last 24 months. This purchase volume represents approximately $47.27 M in transactions.